PARTNER NEWS:Wed, Feb 28, 8:55 AM, Zacks
Wall Street Analysts Think Zentalis Pharmaceuticals, Inc. (ZNTL) Could Surge 136.44%: Read This Before Placing a Bet The consensus price target hints at a 136.4% upside potential for Zentalis Pharmaceuticals, Inc. (ZNTL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Thu, Feb 8, 11:00 AM, Zacks
What Makes Zentalis Pharmaceuticals, Inc. (ZNTL) a New Buy Stock Zentalis Pharmaceuticals, Inc. (ZNTL) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Featured MNV Articles: Orchestra BioMed Holdings is Now Oversold (OBIO)
Friday, April 26, 4:33 PM ET, by Market News Video Staff
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...
Noah Holdings (NOAH) Shares Cross Above 200 DMA
Friday, April 26, 4:10 PM ET, by Market News Video Staff
In trading on Friday, shares of Noah Holdings Ltd (NOAH) crossed above their 200 day ...
Shares of SHM Now Oversold
Friday, April 26, 4:10 PM ET, by Market News Video Staff
In trading on Friday, shares of the SPDR Nuveen Bloomberg Short Term Municipal Bond ETF ...
Notable Two Hundred Day Moving Average Cross - CNC
Friday, April 26, 4:10 PM ET, by Market News Video Staff
In trading on Friday, shares of Centene Corp (CNC) crossed below their 200 day moving ...
TS Makes Notable Cross Below Critical Moving Average
Friday, April 26, 4:09 PM ET, by Market News Video Staff
In trading on Friday, shares of Tenaris SA (TS) crossed below their 200 day moving ...
|
|
By Dividend Channel Staff, Wednesday, December 31, 7:00 PM ET
|